Correction to: Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668916/
https://www.ncbi.nlm.nih.gov/pubmed/38028952
http://dx.doi.org/10.1093/crocol/otad071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668916/
https://www.ncbi.nlm.nih.gov/pubmed/38028952
http://dx.doi.org/10.1093/crocol/otad071

Ejemplares similares